|
2008
|
Invention
|
Modulators of urotensin receptor and methods of use thereof. Provided are compounds that are modu... |
|
|
Invention
|
Quinoline urotensin-ii receptor antagonists. Provided are compounds that are modulators of uroten... |
|
|
Invention
|
Thiophene-2-carboxamide derivatives as modulators of ccr9 receptor.
Provided are... |
|
|
Invention
|
Thiophene-2-carboxamide derivatives as modulators of ccr9 receptor. Provided are compounds of For... |
|
|
Invention
|
Modulators of ccr9 receptor and methods of use thereof.
Provided are compounds th... |
|
|
Invention
|
Modulators of ccr9 receptor and methods of use thereof. Provided are compounds that are modulator... |
|
|
Invention
|
Formulations of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino]sulfonyl}-2-... |
|
|
Invention
|
Formulations of n-(2-acetyl-4,6-dimethylphenyl)-3--2-thiophenecarboxamide.
Provided herein are i... |
|
|
Invention
|
Methods an compositions for treatment of an interstitial lung disease. Provided herein are method... |
|
2007
|
Invention
|
Modulators of c3a receptor and methods of use thereof.
Provided are compounds that are modulator... |
|
|
Invention
|
Modulators of c3a receptor and methods of use thereof. Provided are compounds that are modulators... |
|
|
Invention
|
Processes for the preparation of 4-chloro-3-methyl-5-(2-(2-(6-methylbenzo[d][1,3]dioxol-5-yl)acet... |
|
|
Invention
|
Processes for the preparation of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)a... |
|
|
Invention
|
Polymorphs of n-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)-amino]sulfonyl}-2-t... |
|
|
Invention
|
N- (4-chl0r0-3-methyl-5-is0xaz0lyl) -2- [2-methyl-4, 5- (methylenedioxy) phenylacetyl] -thiophene... |
|
|
Invention
|
Crystalline n-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-methyl-4.5-(methylenedioxy)phenylacetyl]-thio... |
|
|
Invention
|
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists. ... |
|
|
Invention
|
Methods and compositions for treatment of sleep apnea.
Provided herein are methods of treatment ... |
|
|
Invention
|
Methods and compositions for treatment of sleep apnea related applications. Provided herein are m... |
|
|
Invention
|
Methods and compositions for treatment of sleep apnea comprising administration of an endothelin ... |
|
|
Invention
|
Formulations of sitaxsentan sodium.
Provided herein are stable lyophilized and oral formulations... |
|
|
Invention
|
Methods and compositions for treatment of diastolic heart failure.
Provided herein are methods o... |
|
|
Invention
|
Polymorphs of n-(4-chloro-3-methyl-5-isoxazolyl)2-[2-methyl-4,5-(methylenedioxy)phenylacetyl]thio... |
|
|
Invention
|
Formulations of sitaxsentan sodium. Provided herein are stable lyophilized and oral formulations ... |
|
|
Invention
|
Methods and compositions for treatment of diastolic heart failure. Provided herein are methods of... |
|
|
Invention
|
Polymorphs of n-(4-chloro-3-methyl-5-isoxazolyl)2-⏧2-methyl-4,5-(methylenedioxy) phenylacetyl&rsq... |
|
2005
|
Invention
|
Endothelin a receptor (eta) antagonists in combination with phosphodiesterase 5 inhibitors (pde5)... |
|
|
Invention
|
Carboxylic acid derivatives that inhibit the binding of integrins to their receptors. 1 is involved. |
|
2004
|
Invention
|
Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists. The present invention r... |
|
|
Invention
|
Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-ii receptor antagonists..... |
|
|
Invention
|
Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists.
The present... |
|
|
Invention
|
Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists.
The present ... |
|
2003
|
Invention
|
Combination products with carboxylic acid derivatives that inhibit the binding of integrins to th... |
|
|
Invention
|
Sulfonamides and derivatives thereof that modulate the activity of endothelin. Thienyl-, furyl- a... |
|
1996
|
Invention
|
Process to inhibit binding of the integrin α4β1 , to vcam-1 fibronectin and cyclic peptides there... |
